Skip to main content

Table 1 MiR-182-5p expression in LUAD data from RT-qPCR

From: MiR-182-5p and its target HOXA9 in non-small cell lung cancer: a clinical and in-silico exploration with the combination of RT-qPCR, miRNA-seq and miRNA-chip

Clinicopathological parameters n Relevant expression of miR-182-5p (2−ΔCq)
Mean ± SD t/F-value p-value
Tissue LUAD 101 30.371 ± 5.475 14.035 < 0.001*
Noncancerous 101 22.908 ± 3.728
Gender Male 56 29.923 ± 5.567 1.150 0.253
Female 45 28.609 ± 5.879
Age (years) < 60 41 30.642 ± 5.238 1.964 0.053
≥60 60 28.446 ± 5.899
Smoke No 26 31.159 ± 5.435 0.602 0.550
Yes 18 30.138 ± 5.671
Tumor size ≤3 cm 53 25.041 ± 4.651 −13.541 < 0.001*
> 3 cm 48 34.082 ± 1.343
Vascular invasion No 70 28.986 ± 5.839 −0.927 0.356
Yes 31 30.130 ± 5.441
TNM I-II 44 26.730 ± 5.442 −4.377 < 0.001*
III-IV 57 31.350 ± 5.114
Lymph node metastasis No 45 26.478 ± 5.243 −5.023 < 0.001*
Yes 56 31.635 ± 5.036
Pathological grading I 17 27.642 ± 5.863 0.915b 0.404
II 61 29.753 ± 5.713
III 23 29.489 ± 5.641
  1. LUAD: lung adenocarcinoma; SD: standard deviation
  2. * The results were statistically significant (P < 0.05)